SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-15-002781
Filing Date
2015-06-09
Accepted
2015-06-09 17:21:13
Documents
11
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 c81596_10q.htm 10-Q 630579
2 c81596_ex31-1.htm EX-31.1 9228
3 c81596_ex31-2.htm EX-31.2 9222
4 c81596_ex32-1.htm EX-32.1 3340
5 c81596_ex32-2.htm EX-32.2 3357
  Complete submission text file 0000930413-15-002781.txt   6148795

Data Files

Seq Description Document Type Size
6 enz-20150430.xml EX-101.INS 1030673
7 enz-20150430.xsd EX-101.SCH 53932
8 enz-20150430_cal.xml EX-101.CAL 42470
9 enz-20150430_def.xml EX-101.DEF 217724
10 enz-20150430_lab.xml EX-101.LAB 324977
11 enz-20150430_pre.xml EX-101.PRE 226781
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 15921704
SIC: 8071 Services-Medical Laboratories